Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients

The choices for healthy outcomes in caring for end-stage renal disease (CHOICE) study

Tanushree Banerjee, S. Joseph Kim, Brad Astor, Tariq Shafi, Josef Coresh, Neil R. Powe

Research output: Contribution to journalArticle

Abstract

Background Few reports have shown an association between access type and inflammatory marker levels in a longitudinal cohort. We investigated the role of access type on serial levels of inflammatory markers and the role of inflammatory markers in mediating the association of access type and risk of mortality in a prospective study of incident dialysis patients.

Study Design Cohort study, post hoc analysis of the CHOICE (Choices for Healthy Outcomes in Caring for ESRD) study.

Setting & Participants In 583 participants, inflammation was assessed by measuring serum C-reactive protein (CRP) and interleukin 6 (IL-6) after access placement and at multiple times during 3 years' follow-up. Type of access was categorized as central venous catheter (CVC), arteriovenous graft (AVG), and arteriovenous fistula (AVF), and changes over time were recorded. Predictor Access type, age, sex, race, body mass index, diabetes, cardiovascular disease, and serum albumin level. Outcomes CRP level, IL-6 level, and mortality. Measurements We used mixed-effects pattern mixture models to study the association between access type and repeated measurements of inflammation and survival analysis to investigate the association of access type and mortality, adjusting for predictors.

Results In a mixed-effects pattern mixture model, compared with AVFs, the presence of CVCs and AVGs was associated with 62% (P = 0.02) and 30% (P = 0.05) increases in average CRP levels, respectively. A Cox proportional hazards model yielded nonsignificant associations of CVC and AVG use (vs AVFs) with risk of mortality when adjusted for inflammatory marker levels. Higher CRP levels were associated with increased risk of CVC failure than lower CRP levels.

Limitations CRP and IL-6 measurements not performed for all hemodialysis patients.

Conclusions CVCs, compared with AVFs, are associated with a greater state of inflammation in incident hemodialysis patients, and the association of catheter use and mortality may be mediated by access-induced inflammation. Our findings support recommendations for the early removal or avoidance of CVC placements.

Original languageEnglish (US)
Pages (from-to)954-961
Number of pages8
JournalAmerican Journal of Kidney Diseases
Volume64
Issue number6
DOIs
StatePublished - Dec 1 2014

Fingerprint

C-Reactive Protein
Chronic Kidney Failure
Blood Vessels
Renal Dialysis
Central Venous Catheters
Mortality
Inflammation
Interleukin-6
Transplants
Arteriovenous Fistula
Survival Analysis
Proportional Hazards Models
Serum Albumin
Blood Proteins
Dialysis
Body Mass Index
Cohort Studies
Cardiovascular Diseases
Catheters
Prospective Studies

Keywords

  • access failure
  • access patency
  • biomarker
  • C-reactive protein (CRP)
  • central venous catheter (CVC)
  • Cox proportional hazard model
  • end-stage renal disease (ESRD)
  • hemodialysis
  • inflammation
  • interleukin 6 (IL-6)
  • mixed-effects model
  • vascular access type

ASJC Scopus subject areas

  • Nephrology

Cite this

Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients : The choices for healthy outcomes in caring for end-stage renal disease (CHOICE) study. / Banerjee, Tanushree; Kim, S. Joseph; Astor, Brad; Shafi, Tariq; Coresh, Josef; Powe, Neil R.

In: American Journal of Kidney Diseases, Vol. 64, No. 6, 01.12.2014, p. 954-961.

Research output: Contribution to journalArticle

@article{322b4bbc2513464d977d749686cf96cf,
title = "Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: The choices for healthy outcomes in caring for end-stage renal disease (CHOICE) study",
abstract = "Background Few reports have shown an association between access type and inflammatory marker levels in a longitudinal cohort. We investigated the role of access type on serial levels of inflammatory markers and the role of inflammatory markers in mediating the association of access type and risk of mortality in a prospective study of incident dialysis patients.Study Design Cohort study, post hoc analysis of the CHOICE (Choices for Healthy Outcomes in Caring for ESRD) study.Setting & Participants In 583 participants, inflammation was assessed by measuring serum C-reactive protein (CRP) and interleukin 6 (IL-6) after access placement and at multiple times during 3 years' follow-up. Type of access was categorized as central venous catheter (CVC), arteriovenous graft (AVG), and arteriovenous fistula (AVF), and changes over time were recorded. Predictor Access type, age, sex, race, body mass index, diabetes, cardiovascular disease, and serum albumin level. Outcomes CRP level, IL-6 level, and mortality. Measurements We used mixed-effects pattern mixture models to study the association between access type and repeated measurements of inflammation and survival analysis to investigate the association of access type and mortality, adjusting for predictors.Results In a mixed-effects pattern mixture model, compared with AVFs, the presence of CVCs and AVGs was associated with 62{\%} (P = 0.02) and 30{\%} (P = 0.05) increases in average CRP levels, respectively. A Cox proportional hazards model yielded nonsignificant associations of CVC and AVG use (vs AVFs) with risk of mortality when adjusted for inflammatory marker levels. Higher CRP levels were associated with increased risk of CVC failure than lower CRP levels.Limitations CRP and IL-6 measurements not performed for all hemodialysis patients.Conclusions CVCs, compared with AVFs, are associated with a greater state of inflammation in incident hemodialysis patients, and the association of catheter use and mortality may be mediated by access-induced inflammation. Our findings support recommendations for the early removal or avoidance of CVC placements.",
keywords = "access failure, access patency, biomarker, C-reactive protein (CRP), central venous catheter (CVC), Cox proportional hazard model, end-stage renal disease (ESRD), hemodialysis, inflammation, interleukin 6 (IL-6), mixed-effects model, vascular access type",
author = "Tanushree Banerjee and Kim, {S. Joseph} and Brad Astor and Tariq Shafi and Josef Coresh and Powe, {Neil R.}",
year = "2014",
month = "12",
day = "1",
doi = "10.1053/j.ajkd.2014.07.010",
language = "English (US)",
volume = "64",
pages = "954--961",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients

T2 - The choices for healthy outcomes in caring for end-stage renal disease (CHOICE) study

AU - Banerjee, Tanushree

AU - Kim, S. Joseph

AU - Astor, Brad

AU - Shafi, Tariq

AU - Coresh, Josef

AU - Powe, Neil R.

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Background Few reports have shown an association between access type and inflammatory marker levels in a longitudinal cohort. We investigated the role of access type on serial levels of inflammatory markers and the role of inflammatory markers in mediating the association of access type and risk of mortality in a prospective study of incident dialysis patients.Study Design Cohort study, post hoc analysis of the CHOICE (Choices for Healthy Outcomes in Caring for ESRD) study.Setting & Participants In 583 participants, inflammation was assessed by measuring serum C-reactive protein (CRP) and interleukin 6 (IL-6) after access placement and at multiple times during 3 years' follow-up. Type of access was categorized as central venous catheter (CVC), arteriovenous graft (AVG), and arteriovenous fistula (AVF), and changes over time were recorded. Predictor Access type, age, sex, race, body mass index, diabetes, cardiovascular disease, and serum albumin level. Outcomes CRP level, IL-6 level, and mortality. Measurements We used mixed-effects pattern mixture models to study the association between access type and repeated measurements of inflammation and survival analysis to investigate the association of access type and mortality, adjusting for predictors.Results In a mixed-effects pattern mixture model, compared with AVFs, the presence of CVCs and AVGs was associated with 62% (P = 0.02) and 30% (P = 0.05) increases in average CRP levels, respectively. A Cox proportional hazards model yielded nonsignificant associations of CVC and AVG use (vs AVFs) with risk of mortality when adjusted for inflammatory marker levels. Higher CRP levels were associated with increased risk of CVC failure than lower CRP levels.Limitations CRP and IL-6 measurements not performed for all hemodialysis patients.Conclusions CVCs, compared with AVFs, are associated with a greater state of inflammation in incident hemodialysis patients, and the association of catheter use and mortality may be mediated by access-induced inflammation. Our findings support recommendations for the early removal or avoidance of CVC placements.

AB - Background Few reports have shown an association between access type and inflammatory marker levels in a longitudinal cohort. We investigated the role of access type on serial levels of inflammatory markers and the role of inflammatory markers in mediating the association of access type and risk of mortality in a prospective study of incident dialysis patients.Study Design Cohort study, post hoc analysis of the CHOICE (Choices for Healthy Outcomes in Caring for ESRD) study.Setting & Participants In 583 participants, inflammation was assessed by measuring serum C-reactive protein (CRP) and interleukin 6 (IL-6) after access placement and at multiple times during 3 years' follow-up. Type of access was categorized as central venous catheter (CVC), arteriovenous graft (AVG), and arteriovenous fistula (AVF), and changes over time were recorded. Predictor Access type, age, sex, race, body mass index, diabetes, cardiovascular disease, and serum albumin level. Outcomes CRP level, IL-6 level, and mortality. Measurements We used mixed-effects pattern mixture models to study the association between access type and repeated measurements of inflammation and survival analysis to investigate the association of access type and mortality, adjusting for predictors.Results In a mixed-effects pattern mixture model, compared with AVFs, the presence of CVCs and AVGs was associated with 62% (P = 0.02) and 30% (P = 0.05) increases in average CRP levels, respectively. A Cox proportional hazards model yielded nonsignificant associations of CVC and AVG use (vs AVFs) with risk of mortality when adjusted for inflammatory marker levels. Higher CRP levels were associated with increased risk of CVC failure than lower CRP levels.Limitations CRP and IL-6 measurements not performed for all hemodialysis patients.Conclusions CVCs, compared with AVFs, are associated with a greater state of inflammation in incident hemodialysis patients, and the association of catheter use and mortality may be mediated by access-induced inflammation. Our findings support recommendations for the early removal or avoidance of CVC placements.

KW - access failure

KW - access patency

KW - biomarker

KW - C-reactive protein (CRP)

KW - central venous catheter (CVC)

KW - Cox proportional hazard model

KW - end-stage renal disease (ESRD)

KW - hemodialysis

KW - inflammation

KW - interleukin 6 (IL-6)

KW - mixed-effects model

KW - vascular access type

UR - http://www.scopus.com/inward/record.url?scp=84910654278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84910654278&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2014.07.010

DO - 10.1053/j.ajkd.2014.07.010

M3 - Article

VL - 64

SP - 954

EP - 961

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 6

ER -